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Many viruses have the ability to rapidly develop resistance against antiviral drugs and escape from the host immune system.
To which extent the host environment affects this adaptive potential of viruses is largely unknown. Here we show that for HIV-
1, the host-cell environment is key to the adaptive potential of the virus. We performed a large-scale selection experiment with
two HIV-1 strains in two different T-cell lines (MT4 and C8166). Over 110 days of culture, both virus strains adapted rapidly to
the MT4 T-cell line. In contrast, when cultured on the C8166 T-cell line, the same strains did not show any increase in fitness. By
sequence analyses and infections with viruses expressing either yellow or cyan fluorescent protein, we were able to show that
the absence of adaptation was linked to a lower recombination rate in the C8166 T-cell line. Our findings suggest that if we can
manipulate the host-cellular factors that mediate viral evolution, we may be able to significantly retard viral adaptability.
Citation: van Opijnen T, de Ronde A, Boerlijst MC, Berkhout B (2007) Adaptation of HIV-1 Depends on the Host-Cell Environment. PLoS ONE 2(3):
e271. doi:10.1371/journal.pone.0000271
INTRODUCTION
Disease progression in HIV-1 infected patients shows extensive
variation; some patients efficiently suppress HIV-1 for more than
15 years while others develop AIDS within several years [1,2].
Disease progression is related to the viral set-point and viral load,
and patient to patient variability can be explained, to some extent,
by the efficacy of the host-immune response [3], which is
influenced by e.g. the CD4+repertoire, CD8+repertoire and
antibodies [4]. Without intervention, the virus almost always
brakes through the host defenses and the patient will eventually
develop AIDS. One of the most important and hard to battle
characteristics of HIV-1 is its large adaptive potential. It is this
potential that makes the virus escape from the host-immune
system and resistant to anti-retroviral drugs. Several viral-
characteristics that contribute to HIV-19s adaptive potential are
its short generation time [5,6], high copy numbers [7,8], and high
mutation rate [9]. In addition, recombination may be important,
for example, in combining resistance mutations into a single
genome to achieve drug-resistance [10,11]. The host may also
affect the adaptive potential of the virus. For instance different
target cell environments support differential viral replication rates
[12], generation time [13] and recombination rates [14]. Thus, the
adaptive potential of HIV-1 is both shaped by the virus and the
interaction between the virus and the host-environment. To which
extent the host affects the adaptability of HIV-1, however, is still
largely unexplored.
One viral trait that contributes to an unknown degree to the
adaptive potential of HIV-1 is viral recombination. For effective
recombination to occur in HIV-1, a single host-cell needs to be
infected with two distinct viral strains. This double infected cell
can then produce viral particles with a mixed dimeric RNA
genome. Subsequently, cells infected by such heterozygous virions
can obtain a hybrid provirus due to template switching during
reverse transcription [15,16]. Recombination may be important,
for example, in combining resistance mutations into a single
genome to achieve fully drug-resistant strains [10,11]. However,
until now the contribution of recombination to HIV-1 evolution
has been predominantly shown in an indirect manner, through
sequence analyses [17–19] and in silico studies [20–22]. It is not
indisputably clear whether recombination always leads to a higher
rate of adaptation. The Fisher-Muller model predicts that in
asexuals (non-recombining individuals) two beneficial mutations
have to be fixed sequentially, whereas recombination can combine
beneficial mutations that have evolved in parallel. Furthermore,
since asexual organisms have genetically linked loci, in theory they
are more prone to the accumulation of deleterious mutations. On
the other hand recombination may be disadvantageous since the
net effect may result in breaking up favorable combinations of
mutations more often than combining beneficial mutations [23–
27]. In addition, recombination may not be an essential process,
since if the mutation rate is sufficiently high and the population
size large, genomes carrying multiple beneficial mutations should
appear even in asexual populations [28,29].
In this study we set out to determine whether the host-cell
environment can affect the adaptability of HIV-1 in vitro. Two
HIV-1 strains were each cultured in two different T-cell lines
(MT4 and C8166) for 110 days (with six replicas for each
treatment; making a total of 24 serial passage lines). Relative viral
fitness was determined at regular time intervals by letting the
evolved viral strains compete against a reference strain. All viruses
cultured in the MT4 T-cell line increased rapidly in fitness while
viruses cultured in the C8166 T-cell line did not show any increase
in fitness. Through sequence analyses and infections with HIV-1
strains expressing fluorescent protein we were able to relate the
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recombination of HIV-1 in this T cell-line.
RESULTS
Serial passage of two HIV-1 strains on MT4 and
C8166 T-cells
To assess to what degree the host-cell environment influences the
adaptability of HIV-1 we performed a large-scale selection
experiment with two distinct HIV-1 strains in two T-cell lines
(MT4 and C8166). The ‘wild type’ (wt) virus is the widely used
molecular clone pLAI [30], whereas, the mutant (mt) virus lacks
one NF-kB DNA-binding site in its Long Terminal Repeat (LTR)
transcriptional promoter, and is therefore expected to have
a reduced initial fitness [31]. MT4 and C8166 are two genetically
distinct T-cell lines, which have been immortalized by the human
T-cell-leukemia-lymphoma virus type-I [32]. We have shown
previously that mutations in the transcriptional promoter have
different fitness effects when tested in the MT4 and C8116 cell line
[33]. This suggests that differences in cellular environment may
affect the evolutionary outcome of a replicating virus. Initial
relative fitness and replication efficiency were determined for both
viruses in the MT4 and C8166 T-cell lines (Table 1 and
Supplemental Figure S1), which indicates that viral population
size and expansion were similar between cellular environments. As
expected initial wt viral fitness was significantly higher than mt
viral fitness in both cell lines (two-tailed t-test,p ,0.0001). Wt and mt
viruses were used to infect MT4 and C8166 T-cells to establish 24
serial passage lines (six replicates for each virus and cell line
combination). Over a period of 110 days, virus was harvested from
each culture at peak infection (typically after 4 to 6 days) and
subsequently used to infect a ‘fresh’ batch of cells. Each time after
serial passage the same initial viral density and number of host
cells were used. Host cell populations typically expanded from 10
6
to 10
7 cells over 3–4 days, and no significant differences in growth
between cell lines (non-infected and infected) were found.
Since the wt and mt virus have not been specifically adapted to
either cell line we expected to observe a fitness increase for all
serial passage lines [34]. Indeed, the six wt replicates cultured in
the MT4 T-cell line (wt-MT4), increased rapidly in fitness in
a seemingly linear fashion and reached a significantly higher
fitness level of 1.5460.14 over the course of the experiment
(Figure 1A; Table 2, ANOVA,F 1,9=11.276-16.350, p,0.0001).
The six mt-MT4 serial passage lines initially also displayed a rapid
fitness increase and they too reached a significant higher final
fitness around 1.0460.02 (Figure 1B, Table 2, ANOVA,F 1,9=
10.713-16.904, p,0.0001). However, fitness increase in the mt
lines decelerated over the course of the selection experiment and
seemed to reach a plateau, which was confirmed by the superior fit
of an exponential model with an upper limit over that of a linear
model (Figure 1B, F-test, p,0.05 for all replicates). The final fitness
values of the mt replicates are well below that of the wt replicates
(ANOVA,p ,0.001 with Bonferroni correction). This indicates that
the functional defect of the mt strain caused the virus to ‘lock’ on
a lower fitness peak in the adaptive landscape [35,36], at least for
the duration of the experiment.
Surprisingly, none of the twelve serial passage lines that were
cultured on C8166 T-cells significantly changed their fitness
(Figure 1C and, D, Table 3, ANOVA,F 1,9=0.062-2.164, p.0.05).
There are several potential explanations for this apparent lack of
adaptation. First, the basic mutation rate might be low in the
C8166 T-cell line as compared to the MT4 T-cell line. This,
however, is unlikely since the mutation rate depends mainly on the
viral reverse transcriptase enzyme, which was identical in all
situations. Besides, we confirmed by sequence analysis that the
basic mutation rate was similar in both cell lines (see next section).
Second, there may have been fewer adaptive mutations available
in the C8166 T-cell line, for instance, because the initial viral
strains were already better adapted to the C8166 T-cell line than
to the MT4 cell line. We were able to dismiss this possibility as it
turned out that the viruses that were cultured on the MT4 line also
had a significantly higher fitness on the C8166 cell-line (Table 2,
ANOVA,F 1,3=6.367-17.874, p,0.01), which illustrates that in
principle adaptation to the C8166 cell line was possible. As a cross-
check, we also determined fitness of the C8166 serial passage lines
on the MT4 T-cell line, which demonstrates that these viruses had
not changed their fitness on MT4 cells (Table 3, ANOVA,
F1,3=0.117-2.842, p.0.05). These data illustrate that both wt
and mt virus had a large adaptive potential. In spite of this
potential, none of the C8166 cultured viruses had increased their
fitness, neither on C8166 cells nor on MT4 cells.
Table 2. Relative fitness
a (6s.e.m.) of wt and mt virus after
110 days of culture in the MT4 T-cell line
......................................................................
Virus and
cell type of
culture Cell type-MT4 Cell type-C8166
Fitness df F
c Fitness df F
d=110
b d=110
wt-1-MT4 1.5360.14
*** 9 13.852
*** 1.3160.05
*** 3 14.094
***
wt-2-MT4 1.4860.11
*** 7 12.338
*** 1.3260.07
* 3 7.030
*
wt-3-MT4 1.5560.13
*** 9 16.350
*** 1.2760.05
* 3 6.367
*
wt-4-MT4 1.5460.13
*** 9 11.276
*** 1.3960.09
*** 3 17.873
***
wt-5-MT4 1.5460.14
*** 9 18.657
*** 1.2260.03
*** 3 17.834
***
wt-6-MT4 1.5760.14
*** 9 14.614
*** 1.2860.06
*** 3 7.360
*
mt-1-MT4 1.0360.01
*** 7 15.032
*** 1.0560.04
*** 3 9.478
**
mt-2-MT4 1.0360.01
*** 9 11.405
*** 0.9960.06
*** 3 17.638
***
mt-3-MT4 1.0360.01
*** 9 10.713
*** 1.0360.05
*** 3 11.768
***
mt-4-MT4 1.0360.01
*** 7 16.904
*** 1.0160.06
*** 3 12.578
***
mt-5-MT4 1.0560.01
*** 7 15.215
*** 1.0060.05
*** 3 12.811
***
mt-6–MT4 1.0360.01
*** 7 14.925
*** 1.0460.02
*** 3 15.496
***
aFitness is relative to reference strain v13
bSignificance of fitness at day 110 was compared to the parental virus (wt/mt–
d0) in an ANOVA containing all fitness samples measured during the
experiment, p value was therefore Bonferroni-corrected for multiple
comparisons
cF statistic was determined in an ANOVA with repeated measures
d.f., degrees of freedom (number of fitness samples measured during
experiment);
* p,0.01
** p,0.001,
*** p,0.0001
doi:10.1371/journal.pone.0000271.t002
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Table 1. Initial relative fitness
a (6s.e.m.) of wt and mt virus
......................................................................
Virus Cell type
MT4 C8166
wt 1.0460.02 1.0260.02
mt 0.8360.02 0.8160.03
aFitness is relative to reference strain v13
wt.mt, p,0.0001
doi:10.1371/journal.pone.0000271.t001
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HIV-1 Environmental Adaptation
PLoS ONE | www.plosone.org 2 March 2007 | Issue 3 | e271High polymorphism and linkage between genetic
regions in C8166 cultured viruses
To determine whether there was a genetic basis for differences in
adaptation we sequenced two domains of the HIV-1 genome; the
LTR and viral Envelope (Env). Each of the 24 serial passage lines
were analyzed by sequencing ten clones for each region and this
was repeated for four time points, whereas for a fifth time point (at
61 days) only Env was sequenced. On average, nucleotide diversity
in both cell lines was similar, which underpins our previous
assumption that the basic mutation rate in both cell lines was
similar (Table 4). There was no significant difference in linkage
disequilibrium between MT4 and C8166 cultures, possibly due to
the overall relatively low genetic variation. Sequence analysis of
the LTR region showed that inactivation of the NF-kB site in the
mt virus was stably present up to the end of the experiment in all
serial passage lines. This confirms that the LTR ‘handicap’
remained present during the time frame of the experiment and this
gives a likely explanation why the mt-MT4 replicates were ‘locked’
on a lower fitness peak compared to wt-MT4.
There was no obvious bias in the observed mutations; all
cultures had a similar number of transitions and transversions and
also synonymous and non-synonymous changes in Env were not
significantly different between cultures (Table 5). After 110 days of
culture four MT4 cultures contained a single point mutation that
had gone to fixation. In three cases this mutation was located in
the LTR region; two of these mutations were transitions (G 224 A
and G 368 A) and the third was a transversion (G 280 C). The
fourth fixed mutation, a non-synonymous substitution at the
second codon position, caused a threonine-to-lysine change in Env
at position+7133. This lack of mutations that have achieved
fixation might be partly due to coexistence of beneficial mutants.
Also adaptive mutations in parts of the genome that we did not
sequence might have contributed to the observed increase in
fitness.
From the sequence analyses two distinct patterns emerge. First,
plotting genetic variation for both regions for viruses cultured on
the MT4 cell line reveals there is no correlation in genetic
variation between the LTR and Env region (n=44, r
2=0.011,
p=0.49; Figure 2a), whereas there is a strong linear correlation in
genetic variation between these two regions in C8166 cultured
viruses (n=39, r
2=0.745, p,0.0001; Figure 2b). Even if we
exclude the two outliers from Figure 2b the strong relationship
remains (n=37, r
2=0.475, p,0.0001). In other words, MT4
Figure 1. Change in relative fitness of viruses cultured on two distinct T-cell lines. A) The 6 wildtype replicates that are cultured on MT4 T-cells
show a linear increase in fitness. The inset shows a single representative example of replicate wt-1. B) The 6 mutant MT4 cultured replicates show an
initial fitness increase that seems to reach a maximum at around a relative fitness of 1.0460.02. All trajectories are best described by an exponential
regression model with an upper limit (F-test, p,0.05). The inset shows a single representative example of replicate mt-1 (see Table 2 for relative
fitness values at day 110). C and D) relative fitness of 6 wt and 6 mt C8166 cultured viruses, respectively. Relative fitness did not significantly deviate
from the starting virus over the course of the experiment (ANOVA, p..0.05; see Table 3 for relative fitness values at day 110). Fitness is relative to
reference strain v13 (also see materials and methods section.
doi:10.1371/journal.pone.0000271.g001
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PLoS ONE | www.plosone.org 3 March 2007 | Issue 3 | e271cultured viruses show no linkage in genetic variation between the
LTR and Env region, which is in accordance with strong selection.
In contrast, C8166 cultured viruses show a strong correlation
between genetic variation in the LTR and Env region, which is
indicative of the variation being (nearly) neutral.
A second pattern emerges from the level of viral polymorphism
in each culture. We observed that the polymorphism level for the
wt-C8166 viruses was twice as high compared to wt-MT4 viruses
(0.37260.044 wt-C8166 vs 0.17960.026 wt-MT4; two tailed t-test
p,0.0001; omitting singletons from the analysis). The same
pattern was present for mt viruses; the polymorphism level being
twice as high in mt-C8166 viruses compared to mt-MT4 viruses
(0.24760.032 mt-C8166 vs 0.13060.018 mt-MT4; two tailed t-test,
p,0.001). In combination with the similar levels of nucleotide
diversity between environments this implies that singletons were at
least two times more common in the MT4 cultures (data not
shown). These results suggest that: i) selective sweeps in the MT4
cultures have triggered a higher number of singletons in this
environment [37], ii) the high polymorphism level in the C8166
cultures could be indicative for ‘clonal interference’ (see below).
Lack of recombination in the C8166 T-cell line
We were interested in how different cellular environments may
drive differences in viral adaptation. We had minimized the
chance that differences in adaptation would be triggered by
differences in: i) population size; both viral population size, cell
population size and expansion size were similar between cultures,
ii) bottlenecks; the same amount of cells were infected with the
same amount of virus, and iii) mutation rate; the mutation rate of
HIV-1 is (mainly) driven by the erroneous nature of the reverse
transcriptase (RT) enzyme, which is produced by the virus itself.
The RT gene was identical in all viruses, and consequently the
basic mutation rate should be similar across viruses. We show in
Table 4 that, indeed, the accumulated nucleotide diversity, which
is the average number of nucleotide differences per site, was
similar between the two cell types.
Nevertheless, we found a strong effect of cellular environment
on adaptation, with strong fitness increase in MT4 and no fitness
increase in C8166. We think this difference in adaptive potential is
possibly caused by differences in recombination rate between the
two cell lines. Based on the genetic analyses, the large number of
singletons in MT4 cultures point to strong selection whereas the
higher polymorphism level in the ‘non-adapted’ C8166 replicates
might be indicative for ‘clonal interference’ between clones with
marginal fitness effects competing to achieve fixation [38–44].
Clonal interference can put a ‘speed limit’ on the rate of evolution.
Recombination can alleviate this restriction by combining
beneficial mutations into a single genome and thus circumvent
competition among strains [45–47]. A second important process
that can slow down adaptation or even result in a decrease in
fitness is Muller’s ratchet, which can be triggered by repeated
bottlenecks [48–51]. Although bottleneck size was the same for
both environments, differences in recombination rate between
environments may have caused the C8166 cultured viruses to be
more affected by Muller’s ratchet and/or by clonal interference
between marginally beneficial mutations.
To directly test for the ‘lack of recombination’ hypothesis we
assessed differences in viral recombination between MT4 and
C8166 T-cells. Here we used modified HIV-1 strains encoding
either the gene expressing yellow or cyan fluorescent protein
(YFP/CFP) [14]. If recombination occurs between specific regions
of the YFP and CFP genes these HIV-1 recombinants will express
modified Green Fluorescent Protein (GFP*) which can be
observed by FACS analysis [14]. MT4 and C8166 cells were
infected with equal amounts of HIV-YFP and HIV-CFP (2
replicates each). Every four days (well before peak of infection)
virus was harvested and a new batch of cells was infected. FACS
Table 3. Relative fitness
a (6s.e.m.) of wt and mt virus after
110 days of culture in the C8166 T-cell line
......................................................................
Virus after
110 days of
culture Cell type-MT4 Cell type-C8166
Fitness df F
c Fitness df F
d=110
b d=110
wt-1-C8166 1.0260.01
ns 3 2.076
ns 1.0160.01
ns 9 0.530
ns
wt-2-C8166 1.0160.01
ns 3 1.753
ns 1.0260.01
ns 9 0.437
ns
wt-3-C8166 1.0160.01
ns 3 2.842
ns 1.0060.03
ns 9 0.562
ns
wt-4-C8166 1.0260.02
ns 3 1.575
ns 1.0360.03
ns 9 0.151
ns
wt-5-C8166 1.0060.02
ns 3 1.443
ns 1.0160.02
ns 9 0.062
ns
wt-6-C8166 1.0160.01
ns 3 1.509
ns 1.0460.02
ns 9 0.754
ns
mt-1-C8166 0.8660.02
ns 1 0.620
ns 0.8260.06
ns 8 1.215
ns
mt-2-C8166 0.7860.06
ns 1 0.254
ns 0.8960.03
ns 8 1.843
ns
mt-3-C8166 0.7960.06
ns 1 0.117
ns 0.8060.05
ns 8 2.164
ns
Mt-4-C8166 0.8760.04
ns 1 0.995
ns 0.8960.04
ns 8 1.016
ns
mt-5-C8166 0.7760.07
ns 1 0.495
ns 0.8660.04
ns 8 1.171
ns
mt-6-C8166 0.7860.06
ns 1 0.277
ns 0.8560.05
ns 8 1.188
ns
aFitness is relative to reference strain v13
bSignificance of fitness at day 110 was compared to the parental virus (wt/mt–
d0) in an ANOVA containing all fitness samples measured during the
experiment, p value was therefore Bonferroni-corrected for multiple
comparisons
cF statistic was determined in an ANOVA with repeated measures
d.f., degrees of freedom (number of fitness samples measured during
experiment); n.s., not significant
doi:10.1371/journal.pone.0000271.t003
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Table 4. Nucleotide diversity (p6s.e.m.)
......................................................................
Virus/Cell type p
wt-MT4 0.004960.001
a
wt-C8166 0.005260.001
a
mt-MT4 0.004460.001
b
mt-C8166 0.003760.006
b
atwo-tailed t-test p=0.85
btwo-tailed t-test p=0.56
doi:10.1371/journal.pone.0000271.t004
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Table 5. Transition/transversion ratio (R) in LTR and Env and
non-synonymous (dN)/synonymous (dS) ratio in Env
(6s.e.m.).
......................................................................
Virus/Cell type R dN/dS
LTR Env Env
wt-MT4 1.48960.147 1.307560.141 0.77860.154
wt-C8166 1.72960.144 1.77660.147 0.83160.248
mt-MT4 1.41260.087 1.70460.285 0.85560.249
mt-C8166 1.54360.260 1.51760.193 0.85560.187
doi:10.1371/journal.pone.0000271.t005
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PLoS ONE | www.plosone.org 4 March 2007 | Issue 3 | e271analysis was performed after two and three rounds of serial passage
(after 8 and 12 days, respectively). After eight days, over ten times
more MT4 cells than C8166 cells displayed recombinant GFP*
(Table 6). After twelve days the differences between cell lines had
increased even further, and now almost 50 times more MT4 cells
expressed GFP*. The differences in recombination correspond to
differences in double infected cells (expressing both YFP and CFP).
We observed 36x and 124x more double infected cells in the MT4
cultures compared to the C8166 cultures, after eight and twelve
days, respectively. These data confirm that effective recombination
occurs less frequently in C8166 cells than in MT4 cells, which is
the result of a lower number of double infections in C8166 cells.
DISCUSSION
Viral genotype can affect the evolutionary outcome
In this paper we set out to determine whether differences in the
host-cell environment can drive divergent evolution of HIV-1. We
tested two different virus strains, one ‘wildtype’ and a deliberately
handicapped mutant, across two distinct T-cell environments.
After 110 days of culture we obtained some very interesting
results. First, we showed that viruses when cultured on MT4 cells
evolved to a higher fitness level. Interestingly, the wild type virus
showed a continual linear increase in fitness, whereas the adaptive
rate of the mutant virus slowed down and a fitness plateau was
reached. As a consequence, the mutant virus obtained a lower
fitness level than the wildtype virus. This suggests that viruses with
a small initial genetic difference can consistently evolve towards
different local fitness peaks in the viral adaptive landscape
[35,36,52]. It also underlines that the viral genotype significantly
contributes to the adaptive potential. This is especially interesting
in the clinical context of viruses that carry drug resistance muta-
tions, for which the virus pays a fitness cost [53]. The virus may
balance this cost by accumulating compensatory mutations [54–
61]. Our results suggest that the adaptive potential of the resistant
genotype may be diminished from that of the original wildtype.
Therefore, it might be advantageous to continue treatment of an
HIV-1 infected patient, even when resistance develops [61–65].
However, this approach needs careful consideration since cross
resistance against other drugs may evolve [66] and there is at least
one example of a drug resistant HIV-1 strain that evolved to
a higher fitness than that of the initial wildtype strain [67].
The host-cell environment affects the evolutionary
potential of HIV-1
The most important finding in our study is that none of the twelve
serial passage lines that were cultured on C8166 cells resulted in an
Figure 2. Genetic variation in the Long Terminal Repeat (LTR) and envelope region (Env) of MT4 and C8166 cultured viruses. For each culture,
ten clones of both the LTR and Env region were sequenced and this was repeated for five points in time. Thus, each data point corresponds to the
amount of genetic variation within a single serial passage line at a certain point in time. Genetic variation (Kimura 2 parameter) is plotted separately
for the two cell-lines. A) No correlation in genetic variation in MT4 evolved viruses was observed (n=44, r
2=0.011, p=0.49). B) There is a strong linear
correlation in genetic variation between the LTR and Env in C8166 cultured viruses (n=39, r
2=0.745, p,0.0001). Even if the two outliers are taken
out, the strong correlation remains (n=37, r
2=0.475, p,0.0001).
doi:10.1371/journal.pone.0000271.g002
Table 6. Recombination in MT4 and C8166 cells
..................................................................................................................................................
Cell line
a, b 8 days 12 days
%
cGFP* %YFP/CFP CA-p24 ng/ml %GFP* %YFP/CFP CA-p24 ng/ml
MT4 0.016560.002 0.01360.002 101620 0.041660.000 0.042360.014 9169
C8166 0.001560.000 0.000360.000 82615 0.000960.000 0.000360.0001 89612
aOn average 5.561.0%cells were infected on days eight and twelve.
bEvery four days virus was harvested and a new batch of cells were infected.
cPercent cells either expressing GFP* or both YFP and CFP.
doi:10.1371/journal.pone.0000271.t006
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
HIV-1 Environmental Adaptation
PLoS ONE | www.plosone.org 5 March 2007 | Issue 3 | e271increase of viral fitness. The subsequent sequence analyses and
infections with fluorescent protein expressing viruses demonstrated
a lower effective recombination rate in C8166 cells, as compared
to MT4 cells. This reduced recombination rate is a likely
candidate to have caused the evolutionary stagnation. Recombin-
ing populations may have several advantages over non-recombin-
ing populations in adapting to a new situation [25–27]. Re-
combination can avoid clonal interference, that is, competition
between mutations of almost equal fitness increase. Furthermore,
non-recombining populations may experience Muller’s ratchet,
which is the stochastic loss of the most fit genotype in the
population due to the gradual accumulation of deleterious
mutations [48–50]. Muller’s ratchet is highly sensitive to drift
and may for instance be triggered by repeated bottlenecks at serial
passage. Moreover, recombination can reduce the mutational
load, which is a deterministic process where deleterious mutations
accumulate in the genome due to insufficient productivity of the
fittest class [27,68,69] and background selection, where the
probability of fixation of a beneficial mutation is lowered if it
arises in a genetic background with low fitness [41,70–72]. All
these mechanisms may have contributed to our results, although it
is impossible at this stage to pinpoint which effects have been most
important.
It is not clear to what extent recombination contributes to the
adaptability of HIV-1 in vivo.A nin silico study by Althaus and
Bonhoeffer [22] indicates that recombination can speed up the
adaptive rate of HIV-1 if the effective population size is sufficiently
large. Also, in vitro experiments have shown that recombination
can be beneficial and can e.g. lead to the rapid emergence of
resistance against multiple drugs [10,11,73]. However, the
conditions in which these experiments were performed, infecting
cells with equal mixtures of two partially resistant strains, strongly
favour the emergence of recombinants, as the beneficial mutations
are already present at high frequency. In this report we show that
the host-cell environment can greatly influence the adaptive
potential of HIV-1. We conclude that differences in co-infection
rate and consequently the effective recombination rate provide
a mechanistic explanation for these differences in adaptability.
Interestingly, two recent publications demonstrate that cellular
factors are involved in mediating viral recombination [14,74]. In
our experiments differences in recombination rate seem to be
largely due to differences in the level of co-infection of host cells,
which could be due to cell-type specific expression levels of the
viral (co)-receptor or other cellular factors. These combined results
raise the exciting possibility to combat retroviral infections by
modulating cellular factors that reduce viral recombination and
consequently the virus’ adaptive potential.
MATERIALS AND METHODS
Virus constructs
Two viruses were used in the selection experiment; the molecular
clone pLAI (wt) [30] and pLAI with an inactivated NF-kB-II site
in its Long Terminal Repeat (mt). The NF-kB-II DNA-binding
site, which is positioned from-105 to-96 relative to the transcrip-
tion start site, was inactivated by exchanging the sequence 59-
GGGACTTTCC-39 with 59-CCCCCCCCCC-39 through a PCR
strategy with a mutagenic primer on the pBlue39LTR and
pBlue59LTR intermediate plasmids as described previously [75].
The mt molecular clone was obtained by insertion of the XhoI-
HindIII fragment of pBlue39LTR into the 39LTR of the HIV-1
molecular clone pLAI and the ClaI-XbaI fragment of pBlue59LTR
into the 59LTR of the HIV-1 molecular clone pLAI.
Cell lines
The human lymphocytic MT4 and C8166 T-cell lines were
cultured in RPMI 1640 (Gibco BRL) supplemented with 10%fetal
calf serum, penicillin (100 units/ml) and streptomycin (100 units/
ml). MT4 and C8166 are T-cell lines that have been immortalized
through transformation by the human T-cell leukemia-lymphoma
virus type I [32]. Although exact differences between the T-cell
lines have not been assessed, several differences are known, for
instance in the pool of available transcription factors such as
ETS1, C/EBP, GATA, NF-kB, STAT5 and SP1 [76–79]. The
cervix carcinoma cell line C33A (ATCC HTB31) was cultured in
Dulbecco’s Modified Eagle’s Medium (Gibco BRL) with the same
supplements. All cell lines were kept at 37uC and 5%CO2.
Virus stocks and replication
C33A cells were calcium phosphate transfected with 5 mg DNA of
the respective molecular clone to produce virus stocks. The virus
concentration was determined by the CA-p24 Enzyme-Linked
ImmunoSorbent Assay (ELISA) [75]. Replication assays were
performed by infecting 10
6 MT4 or C8166 T-cells with 1 ng CA-
p24 virus stock, and virus replication was followed by measuring
CA-p24 production.
Selection experiment
Twenty four cultures were founded by infecting 10
6 MT4 or
C8166 T-cells and 1 ng CA-p24 of virus (wt or mt; 6 replicates
each). Infections were monitored for viral replication by measuring
CA-p24 production in the culture supernatant and by monitoring
syncytia formation by microscopic inspection, with peak of
infection typically reached between 4–6 days of culture. Sub-
sequently, virus was isolated and a fresh batch of cells was infected
(MOI=0.001). The cultures were maintained up to 110 days and
approximately every three days virus and cellular DNA was
isolated and frozen at 280uC.
Competition experiments
Competition experiments were performed against ‘‘virus 13’’ (v13)
to determine relative fitness of wt and mt at the start of the culture
and at specific time points during the selection experiment. v13
contains a single mutation (C to G change at position-68 relative to
the transcription start site) in the Sp1 DNA binding site in the
Long Terminal Repeat. The mutation served as a marker that can
be tracked by sequencing, and makes the v13 virus slightly less fit
compared to wt in MT4 cells, but is indistinguishable in fitness
from wt in C8166 cells [33]. For each competition experiment,
a total of 10
6 cells were infected with v13 and a sample of the
cultured virus of interest (0.5 ng CA-p24 each). Competition
experiments were performed as previously described [12,33] at an
initial multiplicity of infection (MOI) of approximately 0.001. The
relatively small number of viral generations within the competition
experiments, compared to the large initial number of infected cells,
ensures that de novo mutations during the competition experiment
will not affect our fitness estimates. Even if such mutations are
advantageous, they will not reach substantial copy numbers over
the duration of the experiment. Direct evidence for insensitivity of
our method for de novo mutations comes from the high
reproducibility of fitness estimates between replicates and the fact
that we never observed any new mutations in our sequencing [33].
Also recombination is unlikely to affect our fitness estimates
because, as explained in the main text, effective recombination for
HIV depends on multiple infection of cells, and as indicated the
MOI in our experiments is low. Furthermore, we have never
observed recombinant genotypes in our sequencing data [33].
HIV-1 Environmental Adaptation
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competition was continued for three passages by isolating virus
at peak infection and subsequently infecting a fresh batch of host
cells. Total cell DNA was isolated before passage from approxi-
mately 0.25x10
6 cells as described previously [12]. Proviral LTR
sequences were PCR-amplified and sequenced with the-21M13
Big Dye Primer cycle sequencing kit (ABI) to determine the ratio
of both competitors [12,33,80] and subsequently calculate relative
fitness.
Sequencing and genetic analyses
At specific time points (days 18, 43, 61, 77 and 110) we PCR-
amplified the LTR region from position+37 to+668 and the
envelope region from+7010 to+7732 (Supplemental Figure S2A
and S2B). PCR fragments were subsequently cloned into a pCRII-
TOPO vector (Invitrogen) and ten clones were sequenced (forward
and reverse) from each region and serial passage line and for each
time-point (at time point 61 only Env was sequenced) with the Big
Dye Terminator cycle sequencing kit (ABI). In addition, we re-
sequenced two time points for eight cultures to determine whether
our sequencing method was accurately displaying the viral
variation in each culture. Indeed, nucleotide diversity was similar
between original and re-sequenced cultures, although some
specific observed mutations differed. Nucleotide diversity and the
transition/transversion ratio (R) were calculated with MEGAv3.1
[81] and the Kimura 2-parameter model was used to calculate
genetic variation in each genetic region for each serial passage line
(only time points were included when at least eight clones from
each region were successfully sequenced). dN/dS ratio was
calculated with DnaSP [82] The degree of polymorphism in
a replicate was determined by Spi(12pi), where pi is the frequency
of the mutation at a specific site (singletons were excluded).
Fitness calculation and statistics
For each competition experiment we compute the relative fitness
Wm of the mutant, by comparing the fold expansion of the mutant
and wild type [33,83].
Wm ~
ln Nm(T)   d=Nm(0) ½ 
ln Nw(T)   d=Nw(0) ½ 
ð1Þ
In which, Nm(0)and Nw(0) are the initial densities of the mutant
and wild type genotype, respectively, and Nm(T)and Nw(T) are the
corresponding densities at the end of the experiment and d is the
dilution factor. The relative fitness Wm of a mutant is a dimension-
less factor that scales the growth rate of the mutant compared to
the wild type. For simplicity, we assume that mutations affect the
Malthusian (i.e. exponential) net replication rate, as we cannot
distinguish between effects on replication rate or death rate [84].
Actually, our selection regime with expanding host cell populations
and serial passage transfer will tend to select for viral clones that
are able to expand fast. Statistics were performed with the
programs Prism 3.0 and SPSS 12.0.1.
HIV-1 recombination assay
The genes encoding cyan or yellow fluorescent protein (CFP/YFP)
are derived from pECFP-N1 and pEYFP-N1 (Clontech) and were
inserted into the HIV-1 molecular clone pLAI downstream from
the Env-gene and upstream of the Nef-gene. By recombination
between the ECFP and EYFP genes a functional green fluorescent
protein (GFP*) expressing gene is produced [14]. The detection of
cells expressing fluorescent proteins was performed on a LSR-II
FACS (Becton Dickinson) with a 488 nm laser equipped with
standard filters or with adapted bandpass filters. 10
6 MT4 or
C8166 T-cells were infected with 10 ng CA-p24 virus stock, and
virus replication was followed by measuring CA-p24 production.
Due to insertion in the HIV-1 genome of the gene coding for
fluorescent protein, the viruses are somewhat attenuated when
compared to wt pLAI, which explains why a higher viral input was
necessary in these experiments. Every four days (approximately
four days before the peak of infection was reached) virus was
harvested and a new batch of cells were infected. After eight and
twelve days of replication 0.25610
6 to 0.5610
6 T-cells were
analyzed by FACS (the experiments were performed in duplo).
SUPPORTING INFORMATION
Figure S1 Replication efficiency of wt and mt viruses in MT4
and C8166 T-cells. Virus production over time was followed by
measuring CA-p24 in the culture supernatant. The wt virus has
a clear advantage over the mt virus in both host-cell environments.
Found at: doi:10.1371/journal.pone.0000271.s001 (0.78 MB EPS)
Figure S2 A. LTR sequence wt from+37 to+668. Positions are
according to HXB2 numbering. B. Env sequence from+7010
to+7732. Positions are according to HXB2 numbering.
Found at: doi:10.1371/journal.pone.0000271.s002 (0.03 MB
DOC)
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